DUBLIN , Dec. 5, 2014 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/bmmcqn/global_copd_and) has announced the addition of the "Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020" report to their offering.
The COPD and Asthma hold the largest market share within the global respiratory diseases' market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma globally. COPD was the 3rd leading cause for death with 3 million people in 2013. Variety of drug-delivery methods such as oral and parenteral delivery have been deployed for treatment of COPD and Asthma; however, the pulmonary drug delivery system is the most effective drug-delivery technology as compared to the other (stated) conventional methods.
The pulmonary drug delivery system includes devices such as inhalers and nebulizers - that are types of COPD and Asthma devices. Owing to all of the afore-mentioned factors the global COPD and Asthma devices' market was valued at $25.3 billion in 2013. The global COPD and Asthma devices market is segmented based on product/device types - inhalers and nebulizers. There are three types of inhalers, namely Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and Soft Mist Inhalers (SMIs). Currently, MDIs constitute to the largest market share of about 46% of the global COPD and Asthma devices market.
The DPIs is the fastest growing segment owing to the increase in the adoption rate of DPIs (as compared to other types of inhalers). The ability of DPIs to deliver small and large-sized drug molecules, as well as specialty engineered molecules render it to be the most preferred inhaler by the customers (doctors);therefore, contributing largely to the growth of the DPIs segment market.
The other product type segment, i.e. the Nebulizers, is the device wherein the liquid formulation of drug is dispensed with the help of compressed air. There are various types of nebulizers developed and supplied such as Compressor Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers. The nebulizers hold a largest market share in the Home Healthcare application, as the product design of nebulizers offers benefits to debilitated patients, geriatrics and children.
Geographically, the COPD and Asthma devices market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America holds the largest market share followed by Europe.
Patent expiry of many brands (of inhalers) leads to increased development and supply of such devices by local market players in the Asia-Pacific market; also coupled with the increasing prevalence of the COPD and Asthma diseases in the Asia-Pacific region, the factors will render high market share for the Asia-Pacific region, by 2020. Some of the key market players included in the report are GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc., and Baxter International.
Key Topics Covered:
CHAPTER 1 INTRODUCTION
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
CHAPTER 4 GLOBAL COPD AND ASTHMA DEVICES MARKET BY PRODUCT TYPE, 2013-2020, $MILLION
CHAPTER 5 GLOBAL COPD AND ASTHMA DEVICES MARKET BY GEOGRAPHY, 2013-2020, $MILLION
CHAPTER 6 COMPANY PROFILES
- 3M Health Care
- Allied Healthcare Products Inc.
- AstraZeneca Plc
- Baxter International
- GF Healthcare Products
- GlaxoSmithKline Plc
- Lincare Holdings Inc.
- Merck & Co.
- Novartis AG
- Philips Healthcare
- Smith Medicals
- Sunovion Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/bmmcqn/global_copd_and
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets